Category Archives: Pr Newswire

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, July 19, 2024 /PRNewswire/ — Harbour BioMed (the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, today announced a positive profit alert for the six months ended June 30, 2024 (the “Reporting Period”). Based […]

COSTA MESA, Calif., July 18, 2024 /PRNewswire/ — In an era brimming with industry conferences, eQ Technologic, Inc., the developers of the eQube®-DaaS Platform, is making a bold entrance with its inaugural customer conference, exeQuteSM, Oct. 7-10, 2024. Unlike other customer conferences in the data as a service (DaaS) industry, exeQute is set to stand out […]

SEATTLE, July 19, 2024 /PRNewswire/ — VARON, a leading provider of oxygen concentrator solutions, is thrilled to announce the launch of its new line of CPAP (continuous positive airway pressure) and BiPAP (bilevel positive airway pressure) machines. These machines are designed to deliver effective sleep apnea treatment with maximum comfort and personalized features. This innovative line, known […]

This integration allows for the seamless collection of conversational data from ChatGPT Enterprise CHICAGO, July 19, 2024 /PRNewswire/ — Relativity, a global legal technology company, today announced it is integrating with OpenAI’s ChatGPT Enterprise Compliance API. The integration adds ChatGPT Enterprise as a Collect in RelativityOne data source, allowing users to seamlessly collect and process human-to-AI […]

VOQUEZNA is now approved and available to treat the largest category of Gastroesophageal Reflux Disease (GERD) VOQUEZNA met its primary endpoint in its Phase 3 pivotal trial by demonstrating a significant and rapid reduction of heartburn with daily treatment VOQUEZNA represents the first major innovation in GERD treatment in over 30 years and the only […]

BALTIMORE, Md. and BASKING RIDGE, N.J., July 18, 2024 (GLOBE NEWSWIRE) — Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, and Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced a research collaboration. Lisata will deploy the highly sensitive […]

The Company’s Solutions are Trusted by the Health Plans Representing 80% of all U.S. Covered Lives to Deliver HEDIS Results on Time, Improving Clinical Quality and Member Outcomes BOWIE, Md., July 18, 2024 (GLOBE NEWSWIRE) — Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, proudly announces that its Converged Quality software has […]

SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the issuance of a new patent for the company’s SuperNova technology, strengthening its intellectual property portfolio and positioning Calidi to advance its CLD-201 program into […]

BOTHELL, Wash., July 18, 2024 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) today reported favorable safety and tolerability results from the single-ascending dose (SAD) cohorts of the Phase 1 study in healthy volunteers with CDI-988, its potent, oral, pan-viral protease inhibitor. CDI-988 was specifically designed and developed using Cocrystal’s proprietary […]

 NEW YORK, July 18, 2024 /PRNewswire/ — SunCar Technology Group Inc. (“SunCar” or “the Company, NASDAQ: SDA), an innovative leader in cloud-based B2B auto services and auto e-insurance in China, is pleased to announce that it has been selected as the provider of concierge car services for China Merchants Bank (“CMB”, SSE: 600036, SEHK: 3968) Private […]